Spyros D. Chatziefthimiou
Okayama University of Science
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Spyros D. Chatziefthimiou.
PLOS Biology | 2012
Nikos Pinotsis; Spyros D. Chatziefthimiou; Felix Berkemeier; Fabienne Beuron; Irene M. Mavridis; Petr V. Konarev; Dmitri I. Svergun; Edward P. Morris; Matthias Rief; Matthias Wilmanns
The muscle M-band protein myomesin comprises a 36 nm long filament made of repetitive immunoglobulin–helix modules that can stretch to 2.5-fold this length, demonstrating substantial molecular elasticity.
Circulation-cardiovascular Genetics | 2016
Robert Hastings; Carin de Villiers; Charlotte Hooper; Liz Ormondroyd; Alistair T. Pagnamenta; Stefano Lise; Silvia Salatino; Samantha J. L. Knight; Jenny C. Taylor; K Thomson; Linda Arnold; Spyros D. Chatziefthimiou; Petr V. Konarev; Matthias Wilmanns; Elisabeth Ehler; Andrea Ghisleni; Mathias Gautel; Edward Blair; Hugh Watkins; Katja Gehmlich
Background—High throughput next-generation sequencing techniques have made whole genome sequencing accessible in clinical practice; however, the abundance of variation in the human genomes makes the identification of a disease-causing mutation on a background of benign rare variants challenging. Methods and Results—Here we combine whole genome sequencing with linkage analysis in a 3-generation family affected by cardiomyopathy with features of autosomal dominant left ventricular noncompaction cardiomyopathy. A missense mutation in the giant protein titin is the only plausible disease-causing variant that segregates with disease among the 7 surviving affected individuals, with interrogation of the entire genome excluding other potential causes. This A178D missense mutation, affecting a conserved residue in the second immunoglobulin-like domain of titin, was introduced in a bacterially expressed recombinant protein fragment and biophysically characterized in comparison to its wild-type counterpart. Multiple experiments, including size exclusion chromatography, small-angle x ray scattering, and circular dichroism spectroscopy suggest partial unfolding and domain destabilization in the presence of the mutation. Moreover, binding experiments in mammalian cells show that the mutation markedly impairs binding to the titin ligand telethonin. Conclusions—Here we present genetic and functional evidence implicating the novel A178D missense mutation in titin as the cause of a highly penetrant familial cardiomyopathy with features of left ventricular noncompaction. This expands the spectrum of titin’s roles in cardiomyopathies. It furthermore highlights that rare titin missense variants, currently often ignored or left uninterpreted, should be considered to be relevant for cardiomyopathies and can be identified by the approach presented here.
Organic and Biomolecular Chemistry | 2004
Fumio Toda; Kazuhiro Yoshizawa; Shunji Hyoda; Shinji Toyota; Spyros D. Chatziefthimiou; Irene M. Mavridis
The complete resolution of 2,2[prime or minute]-dihydroxy-1,1[prime or minute]-binaphthyl into its enantiomers by inclusion complexation with a commercially available derivative of choline, is reported. The two enantiomers are recovered in >99% ee from the inclusion complexes by simple dissolution in a diethyl ether-water medium and the resolving agent can be recycled.
Acta Crystallographica Section D-biological Crystallography | 2014
Natalia A. Ponomarenko; Spyros D. Chatziefthimiou; I. N. Kurkova; Yuliana Mokrushina; A. V. Stepanova; Ivan Smirnov; Marat E. Avakyan; T. V. Bobik; Mamedov Aé; Vladimir A. Mitkevich; A. A. Belogurov; Olga S. Fedorova; M. V. Dubina; Andrey V. Golovin; Victor S. Lamzin; Alexander A. Makarov; Matthias Wilmanns; A. G. Gabibov
Catalytic antibody variants with κ and λ light-chain constant domains show differences in their crystal structures which lead to subtle changes in catalytic efficiency and thermodynamic parameters as well as in their affinity for peptide substrates.
CrystEngComm | 2007
Spyros D. Chatziefthimiou; Konstantina Yannakopoulou; Irene M. Mavridis
The inclusion of the long conjugated 4-pyridinealdazine molecule in β-cyclodextrin results in a novel trimer association of β-cyclodextrin macrocycles observed for the first time and an unusual face-to-face assembly of hydrated guest dimers inside the cavity.
Science Advances | 2016
Ivan Smirnov; Andrey V. Golovin; Spyros D. Chatziefthimiou; A. V. Stepanova; Y Peng; O.I Zolotareva; A. A. Belogurov; I. N. Kurkova; N. A. Ponomarenko; Matthias Wilmanns; G.M Blackburn; A. G. Gabibov; R.A. Lerner
Robotic QM/MM maturation in silico markedly improved targeted Ig reactivity. In vitro selection of antibodies from large repertoires of immunoglobulin (Ig) combining sites using combinatorial libraries is a powerful tool, with great potential for generating in vivo scavengers for toxins. However, addition of a maturation function is necessary to enable these selected antibodies to more closely mimic the full mammalian immune response. We approached this goal using quantum mechanics/molecular mechanics (QM/MM) calculations to achieve maturation in silico. We preselected A17, an Ig template, from a naïve library for its ability to disarm a toxic pesticide related to organophosphorus nerve agents. Virtual screening of 167,538 robotically generated mutants identified an optimum single point mutation, which experimentally boosted wild-type Ig scavenger performance by 170-fold. We validated the QM/MM predictions via kinetic analysis and crystal structures of mutant apo-A17 and covalently modified Ig, thereby identifying the displacement of one water molecule by an arginine as delivering this catalysis.
Molecular and Cellular Endocrinology | 2015
Irina V. Kravchenko; Vladimir A. Furalyov; Spyros D. Chatziefthimiou; Matthias Wilmanns; Vladimir O. Popov
Expression of insulin-like growth factor 1 (IGF-1) mRNAs splice forms was recently shown to be stimulated by myofibrillar proteins released from the damaged muscle. In this study, we report that individual subfragments of titin and myomesin composed of Fn type III and Ig-like domains can activate expression of two IGF-1 splice forms in cultured myoblasts, both at protein and mRNA levels. Competition studies showed that each of the domain-types interacts with its own receptor. Induction of IGF-1 expression caused by domains of different types showed dissimilar sensitivity to inhibitors of regulatory cascades. The effect of Fn type III domains was more sensitive to inhibition of Ca(2+)/calmodulin dependent protein kinase, whereas the effect of Ig-like domains showed greater sensitivity to the inhibition of the adenylyl cyclase-cAMP-PKA pathway.
Beilstein Journal of Organic Chemistry | 2017
Spyros D. Chatziefthimiou; Mario Inclán; Petros Giastas; Athanasios Papakyriakou; Konstantina Yannakopoulou; Irene M. Mavridis
The enantioselectivity of β-cyclodextrin (β-CD) towards L- and D-N-acetyltryptophan (NAcTrp) has been studied in aqueous solution and the crystalline state. NMR studies in solution show that β-CD forms complexes of very similar but not identical geometry with both L- and D-NAcTrp and exhibits stronger binding with L-NAcTrp. In the crystalline state, only β-CD–L-NAcTrp crystallizes readily from aqueous solutions as a dimeric complex (two hosts enclosing two guest molecules). In contrast, crystals of the complex β-CD–D-NAcTrp were never obtained, although numerous conditions were tried. In aqueous solution, the orientation of the guest in both complexes is different than in the β-CD–L-NAcTrp complex in the crystal. Overall, the study shows that subtle differences observed between the β-CD–L,D-NAcTrp complexes in aqueous solution are magnified at the onset of crystallization, as a consequence of accumulation of many soft host–guest interactions and of the imposed crystallographic order, thus resulting in very dissimilar propensity of each enantiomer to produce crystals with β-CD.
Doklady Biochemistry and Biophysics | 2017
Andrey V. Golovin; Ivan Smirnov; A. V. Stepanova; A. O. Zalevskiy; A. S. Zlobin; N. A. Ponomarenko; A. A. Belogurov; V. D. Knorre; E. N. Hurs; Spyros D. Chatziefthimiou; Matthias Wilmanns; G.M Blackburn; R. M. Khomutov; A. G. Gabibov
It is proposed to perform quantum mechanical/molecular dynamics calculations of chemical reactions that are planned to be catalyzed by antibodies and then conduct a virtual screening of the library of potential antibody mutants to select an optimal biocatalyst. We tested the effectiveness of this approach by the example of hydrolysis of organophosphorus toxicant paraoxon using kinetic approaches and X-ray analysis of the antibody biocatalyst designed de novo.
Acta Crystallographica Section A | 2012
Matthias Wilmanns; Petr V. Konarev; Dmitri I. Svergun; Gabriel Zoldák; Matthias Rief; Fabienne Beuron; Edward P. Morris; Spyros D. Chatziefthimiou
by hybrid structural biology Matthias Wilmanns, Petr Konarev, Dmitri Svergun, Gabriel Zoldak, Matthias Rief, Fabienne Beuron, Ed Morris, & Spyros D. Chatziefthimiou, European Molecular Biology Laboratory Hamburg Unit, Hamburg, Germany, Institute for Biophysics and Munich Center for Integrated Protein Science, Technical University of Munich, Munich, Germany, Section of Structural Biology, The Institute of Cancer Research, Chester Beatty Laboratories, London, United Kingdom. E-mail: [email protected]